다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cancer research : the official organ of the American Association for Cancer Research, Inc, v.66 no.20, 2006년, pp.10057 - 10063
Hwang, Jin-Taek , Kim, Young Min , Surh, Young-Joon , Baik, Haing Woon , Lee, Seong-Kyu , Ha, Joohun , Park, Ock Jin
AI-Helper
AbstractEpidemiologic and experimental evidences indicate that selenium, an essential trace element, can reduce the risk of a variety of cancers. Protection against certain types of cancers, particularly colorectal cancers, is closely associated with pathways involving cyclooxygenase-2 (COX-2). We f...
10.1038/sj.onc.1209071 Zu K, Bihani T, Lin A, et al. Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells. Oncogene 2006; 25: 546-54.
10.1038/nm1102-1196 Gudkov AV. Converting p53 from a killer into a healer. Nat Med 2002; 8: 1196-8.
Rao CV, Wang CQ, Simi B, et al. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res 2001; 61: 3647-52.
10.1093/carcin/21.4.617 Rao CV, Cooma I, Rodriguez JG, et al. Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene) selenocyanate. Carcinogenesis 2000; 21: 617-21.
10.1101/gad.1199104 Corradetti MN, Inoki K, Bardeesy N, et al. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 2004; 18: 1533-8.
10.1016/j.ccr.2004.06.007 Shaw RJ, Bardeesy N, Manning BD, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6: 91-9.
10.1073/pnas.0308061100 Shaw RJ, Kosmatka M, Bardeesy N, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 2004; 101: 3329-35.
10.1074/jbc.M306104200 Lee M, Hwang JT, Lee HJ, et al. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem 2003; 278: 39653-61.
10.1016/0042-6822(88)90302-9 McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988; 163: 614-7.
10.1074/jbc.M507443200 Rattan R, Giri S, Singh AK, et al. 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem 2005; 280: 39582-93.
10.1038/nm0302-289 Pai R, Soreghan B, Szabo IL, et al. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002; 8: 289-93.
10.1038/nm0498-392 Elder DJ, Paraskeva C. COX-2 inhibitors for colorectal cancer. Nat Med 1998; 4: 392-3.
10.1038/nm0798-773 Rustgi AK. Cyclooxygenase-2: the future is now. Nat Med 1998; 4: 773-4.
10.1093/emboj/cdf478 Eliopoulos AG, Dumitru CD, Wang CC, et al. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J 2002; 21: 4831-40.
10.2174/0929867310007011041 De Leval X, Delarge J, Somers F, et al. Recent advances in inducible cyclooxygenase (COX-2) inhibition. Curr Med Chem 2000; 7: 1041-62.
10.1126/science.1116221 Castellone MD, Teramoto H, Williams BO, et al. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis. Science 2005; 310: 1504-10.
10.1016/j.bbcan.2003.09.003 Ruegg C, Dormond O, Mariotti A. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis. Biochim Biophys Acta 2004; 1654: 51-67.
10.2174/1381612033454036 Ferrandez A, Prescott S, Burt RW. COX-2 and colorectal cancer. Curr Pharm Des 2003; 9: 2229-51.
10.1093/carcin/bgh266 Shin VY, Wu WK, Ye YN, et al. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis 2004; 25: 2487-95.
Dong Y, Ganther HE, Stewart C, et al. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res 2002; 62: 708-14.
10.1038/nm1061 Kim MS, Park JY, Namkoong C, et al. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004; 10: 727-33.
10.1096/fj.04-2179fje Atherton PJ, Babraj J, Smith K, et al. Selective activation of AMPK-PGC-1α or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J 2005; 19: 786-8.
10.1242/jcs.01540 Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004; 117: 5479-87.
10.1038/nature02440 Minokoshi Y, Alquier T, Furukawa N, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428: 569-74.
10.1074/jbc.M300215200 Zou MH, Hou XY, Shi CM, et al. Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J Biol Chem 2003; 278: 34003-10.
10.1074/jbc.M509723200 Wagner TM, Mullally JE, Fitzpatrick FA. Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation. J Biol Chem 2006; 281: 2598-604.
10.1016/S0140-6736(00)02490-9 Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-41.
10.1093/carcin/21.8.1531 Chen X, Mikhail SS, Ding YW, et al. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis 2000; 21: 1531-6.
10.1016/j.mrfmmm.2004.02.023 El-Bayoumy K, Sinha R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 2004; 551: 181-97.
10.1016/j.bbrc.2005.09.195 Hwang JT, Park IJ, Shin JI, et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005; 338: 694-9.
10.1016/j.bbrc.2005.04.143 Hwang JT, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 2005; 332: 433-40.
10.1093/carcin/bgh253 Hwang JT, Lee M, Jung SN, et al. AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1α expression in DU145 cells. Carcinogenesis 2004; 25: 2497-507.
10.1074/jbc.M412994200 Yun H, Lee M, Kim SS, et al. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem 2005; 280: 9963-72.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.